Anebulo Pharmaceuticals I...

1.36
-0.04 (-2.86%)
At close: Mar 28, 2025, 3:53 PM
1.36
0.00%
After-hours: Mar 28, 2025, 04:00 PM EDT
-2.86%
Bid 1.15
Market Cap 55.88M
Revenue (ttm) n/a
Net Income (ttm) -11.49M
EPS (ttm) -0.29
PE Ratio (ttm) -4.69
Forward PE -2.37
Analyst Hold
Ask 1.52
Volume 1,847
Avg. Volume (20D) 29,841
Open 1.44
Previous Close 1.40
Day's Range 1.36 - 1.45
52-Week Range 0.80 - 3.30
Beta -1.09

About ANEB

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas....

Industry Biotechnology
Sector Healthcare
IPO Date May 7, 2021
Employees 2
Stock Exchange NASDAQ
Ticker Symbol ANEB
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for ANEB stock is "Hold." The 12-month stock price forecast is $8, which is an increase of 488.24% from the latest price.

Stock Forecasts
4 months ago
-1.94%
Anebulo Pharmaceuticals shares are trading higher ... Unlock content with Pro Subscription